| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Gene (GNAS1) in Albright Hereditary Osteodystrophy1
Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (D.Y., S.Y., L.S.W.), Bethesda, Maryland 20892; Childrens Hospital, University of Wurzburg (V.S.), D-97080 Wurzburg, Germany; Childrens Hospital, University of Lubeck (K.K.), D-23538 Lubeck, Germany; and the Department of Pediatrics, University of New Mexico (C.L.C.), Albuquerque, New Mexico 87131
Address all correspondence and requests for reprints to: Dr. Lee S. Weinstein, Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Building 10, Room 8C101, Bethesda, Maryland 20892-1752. E-mail: leew{at}amb.niddk.nih.gov
Albright hereditary osteodystrophy (AHO) is a genetic disorder
characterized by short stature, skeletal defects, and obesity. Within
AHO kindreds, some affected family members have only the somatic
features of AHO [pseudopseudohypoparathyroidism (PPHP)], whereas
others have these features in association with resistance to multiple
hormones that stimulate adenylyl cyclase within their target tissues
[pseudohypoparathyroidism type Ia (PHP Ia)]. Affected members of most
AHO kindreds (both those with PPHP and those with PHP Ia) have a
partial deficiency of Gs
, the
-subunit of the G
protein that couples receptors to adenylyl cyclase stimulation, and in
a number of cases heterozygous loss of function mutations within the
Gs
gene (GNAS1) have been identified.
Using PCR with the attachment of a high melting domain (GC-clamp) and
temperature gradient gel electrophoresis, two novel heterozygous
frameshift mutations within GNAS1 were found in two AHO
kindreds. In one kindred all affected members (both PHP Ia and PPHP)
had a heterozygous 2-bp deletion in exon 8, whereas in the second
kindred a heterozygous 2-bp deletion in exon 4 was identified in all
affected members examined. In both cases the frameshift encoded a
premature termination codon several codons downstream of the deletion.
In the latter kindred affected members were previously shown to have
decreased levels of GNAS1 messenger ribonucleic acid
expression. These results further underscore the genetic heterogeneity
of AHO and provides further evidence that PHP Ia and PPHP are two
clinical presentations of a common genetic defect. Serial measurements
of thyroid function in members of kindred 1 indicate that TSH
resistance progresses with age and becomes more evident after the first
year of life.
This article has been cited by other articles:
![]() |
A.-S. Balavoine, M. Ladsous, F.-L. Velayoudom, V. Vlaeminck, C. Cardot-Bauters, M. d'Herbomez, and J.-L. Wemeau Hypothyroidism in patients with pseudohypoparathyroidism type Ia: clinical evidence of resistance to TSH and TRH Eur. J. Endocrinol., October 1, 2008; 159(4): 431 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Plagge, G. Kelsey, and E. L Germain-Lee Physiological functions of the imprinted Gnas locus and its protein variants G{alpha}s and XL{alpha}s in human and mouse J. Endocrinol., February 1, 2008; 196(2): 193 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Long, S. McGuire, M. A. Levine, L. S. Weinstein, and E. L. Germain-Lee Body Mass Index Differences in Pseudohypoparathyroidism Type 1a Versus Pseudopseudohypoparathyroidism May Implicate Paternal Imprinting of G{alpha}s in the Development of Human Obesity J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1073 - 1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
S M Park and V K K Chatterjee Genetics of congenital hypothyroidism J. Med. Genet., May 1, 2005; 42(5): 379 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G Riepe, W. Ahrens, N. Krone, R. Folster-Holst, J. Brasch, W. G Sippell, O. Hiort, and C.-J. Partsch Early manifestation of calcinosis cutis in pseudohypoparathyroidism type Ia associated with a novel mutation in the GNAS gene Eur. J. Endocrinol., April 1, 2005; 152(4): 515 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Linglart, J. C. Carel, M. Garabedian, T. Le, E. Mallet, and M. L. Kottler GNAS1 Lesions in Pseudohypoparathyroidism Ia and Ic: Genotype Phenotype Relationship and Evidence of the Maternal Transmission of the Hormonal Resistance J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 189 - 197. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Weinstein, S. Yu, D. R. Warner, and J. Liu Endocrine Manifestations of Stimulatory G Protein {alpha}-Subunit Mutations and the Role of Genomic Imprinting Endocr. Rev., October 1, 2001; 22(5): 675 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ahrens, O. Hiort, P. Staedt, T. Kirschner, C. Marschke, and K. Kruse Analysis of the GNAS1 Gene in Albright's Hereditary Osteodystrophy J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4630 - 4634. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mantovani, R. Romoli, G. Weber, V. Brunelli, E. De Menis, S. Beccio, P. Beck-Peccoz, and A. Spada Mutational Analysis of GNAS1 in Patients with Pseudohypoparathyroidism: Identification of Two Novel Mutations J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4243 - 4248. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |